Myra Shapiro-Feinberg1, Edna Furma-Haran2, Dov Grobgeld3, and Hadassa Degani4
1Meir Medical Center, Kfar Saba, Israel, 2Weizmann Institute of Sience, rehovot, Israel, 3Weizmann Institute of Science, Rehovot, Israel, 4Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
Synopsis
Ellipsoid mapping
of the breast with a specific colorization mode has been developed as a visualization means for evaluating the
entire information embedded in breast Diffusion Tensor Imaging (DTI) and
improve breast cancer detection. The 3D ellipsoid maps were displayed at
voxel resolution with their shape and orientation determined by a
respective eigenvalue-eigenvector pair of the associated diffusion tensor, followed
by colorizing the ellipsoids according to the values of each diffusion tensor
parameter. The results show that the enhanced ellipsoid
mapping with λ1 colorization accentuating breast malignancy, may allow
efficient differentiation of breast malignancy from normal breast tissue.
Purpose
To develop a means for visualizing
multiple clinically important parameters derived from breast Diffusion Tensor Imaging
(DTI) in a single map, enabling faster and more efficient detection and
diagnosis of breast cancer. Introduction
Diffusion MRI has now been
widely introduced into clinical breast imaging as an adjunct to Dynamic
Contrast Enhanced (DCE) imaging, as many previous studies have demonstrated
that lowered Apparent Diffusion Coefficients (ADC) are correlated with highly
cellular regions such as breast cancer and can improve the overall specificity
of the MRI exam1. We have previously shown that specific diffusion
parameters of DTI in the breast, has
exciting potential to serve as a method that
may excludes the need for contrast injection2,3.
DTI scan data is often presented as
a diffusion ellipsoid map, depicting on a voxel-by-voxel basis the
diffusion
direction (eigenvectors) in three orthogonal axes of an ellipsoid shape that
coincides with the diffusion frame of the tissue and the corresponding diffusion coefficients
(eigenvalues λ1, λ2, λ3),
as well as the diffusion anisotropy indices. As the information embedded in the
ellipsoids metrics is clinically relevant, breast malignancies can be depicted
by evaluating changes in the ellipsoids’ form and size in different regions of
the breast. Here we show the potential of enhanced ellipsoid mapping with λ1
colorization accentuating breast malignancy and allowing differentiation of
breast malignancy from normal breast tissue. Methods
This retrospective study
was approved by the IRB of Meir Medical Center. Images were acquired on a 3
Tesla Trio scanner (Siemens). The MRI protocol included DTI sequence using
twice refocused spin echo EPI and fat suppression, TE of 120ms, 60 slices with slice
thickness = 2-2.5 mm, 1.9x1.9mm2 in-plane resolution, diffusion
gradients at b values 0 and 700s/mm2 along 30 or 64 directions with respective
scan times of 6 or 11 min. The DTI datasets were analyzed using a proprietary software2
that calculated the three diffusion coefficient at voxel
resolution followed by a non-linear best fit regression algorithm to calculate
the rank-2 symmetric diffusion tensor followed by diagonalization to yield
three eigenvalue-eigenvector pairs. The 3D
ellipsoid maps were displayed at voxel resolution with the length and
orientation of each of the three principal axes of an ellipsoid determined by the
respective eigenvalue-eigenvector pairs of the associated diffusion tensor. ROC curve analysis and calculation of contrast to
noise ratio (CNR) were performed on datasets of twenty-four patients with
pathology confirmed breast cancer. The ROC curves yielded upper threshold value
for differentiating breast malignancy from normal tissue of each diffusion
tensor parameter. The
ellipsoids were colored according to the different diffusion parameters, using a
color scale with the same upper threshold (0.017mm2/sec threshold of λ1) and
unit scaling or using the upper threshold of each parameter for differentiating
cancer from normal tissue as determined by the ROC curve analysis, keeping the
same unit scaling. Results
The Ellipsoid maps revealed a reduced size and a
more spherical shape of the ellipsoids in breast cancer lesions as compared to the surrounding fibroglandular
tissue, indicating lower diffusion coefficients (λ1, λ2, λ3,
mean diffusivity-MD), and reduced anisotropy, respectively, as
displayed in Figure 1 for a typical invasive ductal carcinoma (IDC). In Fig.1A the
color scale of the three diffusion coefficients is the same showing a decrease from λ1
to λ3 in normal ductal/glandular
regions which reflects high maximal
anisotropy (λ1- λ3), whereas in the cancer
region, the three diffusion coefficients
are similar and λ1-
λ3 is low. Overall the CNR declined from λ1 to λ3 as demonstrated in Fig.
1A and CNRλ1 was higher than CNRMD as demonstrated in Fig. 1B. Ellipsoids’ maps with λ1 colorization also revealed the presence of small cancer lesions, with a size
less than 5 mm, with detection efficiency similar to that of DCE as shown in
Figure 2. Discussion
We developed the means for generating novel diffusion 3D ellipsoids’ maps
from breast DTI scan data, providing a graphical representation of these maps. The fast and comprehensive visualization of the complete diffusion
tensor information over the entire breast, at high spatial resolution, together
with the emphasized coloring of λ1,
the most instructive diffusion coefficient, provide
a new means for efficiently characterizing breast tissue and identify breast malignancy. The clinical evaluation indicated that the
features of malignancy in the ellipsoids maps with λ1 colorization were particularly exposed in dense breasts, where mammography is usually
limited. Further quantitative evaluation of the diagnostic accuracy of the ellipsoids
with λ1 colorization is underway.Acknowledgements
E. Furman-Haran holds
the Calin and Elaine Rovinescu Research Fellow Chair for Brain Research. Prof.
H. Degani holds the Fred and Andrea Fallek Chair for Breast Cancer ResearchReferences
1. Chen X, Li WL,
Zhang YL, et al. Meta-analysis of quantitative diffusion-weighted MR imaging in
the differential diagnosis of breast lesions. BMC Cancer, 2010 Dec 29; 10:693.
doi: 10.1186/1471-2407-10-693.
2. Eyal E,
Shapiro-Feinberg M, Furman-Haran E, et al. Parametric diffusion tensor imaging
of the breast Invest. Radiol, 2012 May; 47(5):284-291. doi:
10.1097/RLI.0b013e3182438e5d.
3. Shapiro-Feinberg M, Weisenberg N, Zehavi T et al. Clinical
results of DTI, Eur J Radiol. 2012 Sep; 81 Suppl
1:S151-2. doi: 10.1016/S0720-048X(12)70063-3.
4. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor
spectroscopy and imaging
Biophys J. 1994 Jan; 66(1):259-67.